Ansell (ASX: ANN) — Perfil da empresa, notícias e dados financeiros
Ansell provides personal protective equipment (PPE) for various industries, focusing on innovation and quality manufacturing.
Ansell
Ansell is a global designer, manufacturer, and marketer of personal protective equipment and safety solutions. The company operates two main business divisions, Industrial and Healthcare, providing hand and body protection products designed for diverse industrial and clinical environments. Its portfolio includes mechanical and chemical protective gloves, surgical and examination gloves, cleanroom garments, anti-fog eyewear, and protective suits. Ansell serves customer segments across automotive, chemical, manufacturing, life sciences, healthcare, and emergency response sectors. Headquartered in Australia, the company maintains manufacturing facilities, research centers, and distribution networks across North America, Latin America, Europe, Asia-Pacific, and the Middle East.
Resumo
Operações
Produtos e/ou serviços de Ansell
- Industrial Mechanical Protection: Gloves and arm sleeves engineered for cut, abrasion, and impact protection, serving industrial workers across automotive, machinery, construction, and logistics sectors. These hand protection solutions incorporate multi-layer fabrics and specialized palm coatings to ensure workplace safety.
- Industrial Chemical & Body Protection: Chemical-resistant gloves, full-body suits, and protective aprons designed to protect workers from hazardous liquid chemicals, toxic sprays, and environmental hazards. They are used extensively across chemical processing, oil and gas, agriculture, and general manufacturing facilities.
- Surgical Safety & Protection: Specialized surgical gloves and operating room safety accessories engineered for infection prevention, barrier integrity, and tactile sensitivity during medical procedures. These sterile solutions support surgeons, clinical teams, and healthcare personnel across global hospital systems.
- Life Sciences & Cleanroom Protection: Sterile cleanroom gloves, anti-fog goggles, coveralls, and contamination control products suited for cleanroom environments. These specialized items prevent human contamination in pharmaceutical manufacturing, biotechnology laboratories, semiconductor fabrication facilities, and life science research centers.
- Medical Examination & Disposable Gloves: Single-use nitrile, latex, and synthetic exam gloves providing barrier protection against biological pathogens, body fluids, and cross-contamination. These disposable products are distributed to hospitals, dental clinics, diagnostic laboratories, and emergency medical services worldwide.
- Safety Assessment & Digital Services: Proprietary safety evaluation services, chemical permeation analysis tools, and clinical education platforms designed to audit workplace hazards. These advisory offerings help industrial enterprise clients select compliant personal protective equipment and manage worker safety protocols.
equipe executiva do Ansell
- Nathalie AhlstromMD, CEO & Director
- Erik van den EndenChief Financial Officer
- John MarsdenChief Operations & Supply Chain Officer
- Deanna JohnstonChief Information Officer
- Michael EvansSenior Director of Investor Relations and Corporate M&A
- Philippe H. RommelChief Legal Officer
- Rob HughesChief Product & Marketing Officer
- Charlotte DollChief Human Resource Officer
- Augusto M. AccorsiChief Commercial Officer of EMEA & APAC
- Sean P. SweeneyChief Commercial Officer of Americas
Últimas notícias sobre a Ansell
Comunicados recentes
O que a Ansell (ANN) comunicou ao mercado, do mais recente para o mais antigo.
- Change in substantial holding
- Notice of 2026 Annual General Meeting
- Change of Director's Interest Notice - N Ahlstrom
- Notification regarding unquoted securities - ANN
- Update - Notification of buy-back - ANN
- Chief Financial Officer Appointment
- Update - Notification of buy-back - ANN
Histórico de dividendos
Dividendos por ação pagos pela Ansell, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | A$0.5808 | — | — | A$0.5808 |
| FY2026 | A$0.4279 | — | — | A$0.8047 |
| FY2025 | A$0.3227 | A$0.3486 | — | A$0.6713 |
| FY2024 | A$0.4031 | A$0.2521 | — | A$0.6552 |
| FY2023 | A$0.4518 | A$0.2915 | — | A$0.7433 |
Principais indicadores financeiros
Resultados divulgados pela Ansell, em USD.
- Cap. de mercado
- 6,4 bi
- Receita (TTM)
- 2,1 bi
- P/L
- 21.3
- LPA (diluído, TTM)
- 2.1
- Dividend yield
- 1.5%
- Margem de lucro
- 9.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,2 bi | 343,3 mi | 213,2 mi | |
| 2 bi | 109,1 mi | 101,6 mi | |
| 1,6 bi | 178,9 mi | 76,5 mi | |
| 1,7 bi | 210,5 mi | 148,3 mi |